ID PLCE_MOUSE Reviewed; 365 AA. AC Q9D1E8; Q3U702; Q8BG61; Q8CGN6; DT 23-JAN-2002, integrated into UniProtKB/Swiss-Prot. DT 16-MAY-2003, sequence version 2. DT 27-MAR-2024, entry version 150. DE RecName: Full=1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon; DE EC=2.3.1.51 {ECO:0000269|PubMed:15367102}; DE AltName: Full=1-acylglycerol-3-phosphate O-acyltransferase 5; DE Short=1-AGP acyltransferase 5; DE Short=1-AGPAT 5; DE AltName: Full=Lysophosphatidic acid acyltransferase epsilon; DE Short=LPAAT-epsilon; GN Name=Agpat5; Synonyms=D8Ertd319e; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=NMRI; RA Lu B., Jiang Y.J., Chan M., Choy P.C.; RT "Identification and characterization of 1-acylglycerolphosphate RT acyltransferase-epsilon."; RL Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J, and NOD; RC TISSUE=Bone marrow, Cerebellum, Dendritic cell, Embryo, and Spleen; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Czech II; TISSUE=Mammary gland; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY. RC STRAIN=C57BL/6J; RX PubMed=15367102; DOI=10.1042/bj20041348; RA Lu B., Jiang Y.J., Zhou Y., Xu F.Y., Hatch G.M., Choy P.C.; RT "Cloning and characterization of murine 1-acyl-sn-glycerol 3-phosphate RT acyltransferases and their regulation by PPARalpha in murine heart."; RL Biochem. J. 385:469-477(2005). CC -!- FUNCTION: Converts 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic CC acid or LPA) into 1,2-diacyl-sn-glycerol-3-phosphate (phosphatidic acid CC or PA) by incorporating an acyl moiety at the sn-2 position of the CC glycerol backbone (PubMed:15367102). Acts on LPA containing saturated CC or unsaturated fatty acids C15:0-C20:4 at the sn-1 position using CC C18:1-CoA as the acyl donor (By similarity). Also acts on CC lysophosphatidylethanolamine using oleoyl-CoA, but not arachidonoyl- CC CoA, and lysophosphatidylinositol using arachidonoyl-CoA, but not CC oleoyl-CoA (By similarity). Activity toward lysophosphatidylglycerol CC not detectable (By similarity). {ECO:0000250|UniProtKB:Q9NUQ2, CC ECO:0000269|PubMed:15367102}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1-acyl-sn-glycero-3-phosphate + an acyl-CoA = a 1,2-diacyl- CC sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:19709, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:57970, ChEBI:CHEBI:58342, CC ChEBI:CHEBI:58608; EC=2.3.1.51; CC Evidence={ECO:0000269|PubMed:15367102}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19710; CC Evidence={ECO:0000305|PubMed:15367102}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + tetradecanoyl-CoA CC = 1-(9Z)-octadecenoyl-2-tetradecanoyl-sn-glycero-3-phosphate + CoA; CC Xref=Rhea:RHEA:37171, ChEBI:CHEBI:57287, ChEBI:CHEBI:57385, CC ChEBI:CHEBI:74544, ChEBI:CHEBI:74579; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37172; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + pentadecanoyl-CoA CC = 1-(9Z)-octadecenoyl-2-pentadecanoyl-sn-glycero-3-phosphate + CoA; CC Xref=Rhea:RHEA:37175, ChEBI:CHEBI:57287, ChEBI:CHEBI:74309, CC ChEBI:CHEBI:74544, ChEBI:CHEBI:74578; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37176; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + octadecanoyl-CoA CC = 1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phosphate + CoA; CC Xref=Rhea:RHEA:37147, ChEBI:CHEBI:57287, ChEBI:CHEBI:57394, CC ChEBI:CHEBI:74544, ChEBI:CHEBI:74552; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37148; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + nonadecanoyl-CoA CC = 1-(9Z)-octadecenoyl-2-nonadecanoyl-sn-glycero-3-phosphate + CoA; CC Xref=Rhea:RHEA:37595, ChEBI:CHEBI:57287, ChEBI:CHEBI:74544, CC ChEBI:CHEBI:75104, ChEBI:CHEBI:75105; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37596; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-3- CC phosphoethanolamine = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3- CC phosphoethanolamine + CoA; Xref=Rhea:RHEA:37499, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:57387, ChEBI:CHEBI:74971, ChEBI:CHEBI:74986; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37500; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-3- CC phosphocholine = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine CC + CoA; Xref=Rhea:RHEA:37387, ChEBI:CHEBI:28610, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:57387, ChEBI:CHEBI:74669; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37388; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-(9Z-octadecenoyl)-sn- CC glycero-3-phospho-(1D-myo-inositol) = 1-(9Z-octadecenoyl)-2- CC (5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-1D-myo-inositol CC + CoA; Xref=Rhea:RHEA:42216, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, CC ChEBI:CHEBI:78762, ChEBI:CHEBI:78765; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42217; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-3- CC phospho-L-serine = 1,2-di-(9Z)-octadecenoyl-sn-glycero-3-phospho-L- CC serine + CoA; Xref=Rhea:RHEA:37407, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:57387, ChEBI:CHEBI:74617, ChEBI:CHEBI:74905; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37408; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-(9Z-octadecenoyl)-sn- CC glycero-3-phospho-L-serine = 1-(9Z-octadecenoyl)-2-(5Z,8Z,11Z,14Z- CC eicosatetraenoyl)-sn-glycero-3-phospho-L-serine + CoA; CC Xref=Rhea:RHEA:37379, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, CC ChEBI:CHEBI:74617, ChEBI:CHEBI:74897; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37380; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-phosphate CC = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA; CC Xref=Rhea:RHEA:33187, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, CC ChEBI:CHEBI:57518, ChEBI:CHEBI:64839; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33188; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-octadecenoyl-CoA + 1-heptadecanoyl-sn-glycero-3-phosphate CC = 1-heptadecanoyl-2-(9Z)-octadecenoyl-sn-glycero-3-phosphate + CoA; CC Xref=Rhea:RHEA:37151, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, CC ChEBI:CHEBI:74554, ChEBI:CHEBI:74556; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37152; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-octadecenoyl-CoA + 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn- CC glycero-3-phosphate = 1-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-2-(9Z)- CC octadecenoyl-sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:37455, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:74938, CC ChEBI:CHEBI:74941; Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37456; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-octadecenoyl-CoA + 1-octadecanoyl-sn-glycero-3-phosphate CC = 1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA; CC Xref=Rhea:RHEA:37163, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, CC ChEBI:CHEBI:74560, ChEBI:CHEBI:74565; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37164; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-(9Z-octadecenoyl)-sn- CC glycero-3-phosphate = 1-(9Z)-octadecenoyl-2-(5Z,8Z,11Z,14Z)- CC eicosatetraenoyl-sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:37443, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, ChEBI:CHEBI:74544, CC ChEBI:CHEBI:74928; Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37444; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + heptadecanoyl-CoA CC = 1-(9Z)-octadecenoyl-2-heptadecanoyl-sn-glycero-3-phosphate + CoA; CC Xref=Rhea:RHEA:37155, ChEBI:CHEBI:57287, ChEBI:CHEBI:74307, CC ChEBI:CHEBI:74544, ChEBI:CHEBI:74558; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37156; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-(9Z-octadecenoyl)-sn- CC glycero-3-phosphocholine = 1-(9Z)-octadecenoyl-2-(5Z,8Z,11Z,14Z)- CC icosatetraenoyl-sn-glycero-3-phosphocholine + CoA; CC Xref=Rhea:RHEA:37395, ChEBI:CHEBI:28610, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:57368, ChEBI:CHEBI:74671; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37396; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-3- CC phosphate = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA; CC Xref=Rhea:RHEA:37131, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, CC ChEBI:CHEBI:74544, ChEBI:CHEBI:74546; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37132; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + hexadecanoyl-CoA CC = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA; CC Xref=Rhea:RHEA:42592, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, CC ChEBI:CHEBI:64839, ChEBI:CHEBI:74544; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42593; CC Evidence={ECO:0000250|UniProtKB:Q9NUQ2}; CC -!- PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP- CC diacylglycerol from sn-glycerol 3-phosphate: step 2/3. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:Q9NUQ2}; Multi-pass membrane protein CC {ECO:0000255}. Nucleus envelope {ECO:0000250|UniProtKB:Q9NUQ2}. CC Mitochondrion {ECO:0000250|UniProtKB:Q9NUQ2}. CC -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:15367102}. CC -!- DOMAIN: The HXXXXD motif is essential for acyltransferase activity and CC may constitute the binding site for the phosphate moiety of the CC glycerol-3-phosphate. {ECO:0000250|UniProtKB:Q9D517}. CC -!- SIMILARITY: Belongs to the 1-acyl-sn-glycerol-3-phosphate CC acyltransferase family. {ECO:0000305}. CC -!- CAUTION: It is uncertain whether Met-1 or Met-12 is the initiator. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY161042; AAN75571.1; -; mRNA. DR EMBL; AK003649; BAB22915.2; -; mRNA. DR EMBL; AK082137; BAC38421.1; -; mRNA. DR EMBL; AK089885; BAC40983.1; -; mRNA. DR EMBL; AK152709; BAE31436.1; -; mRNA. DR EMBL; AK152889; BAE31572.1; -; mRNA. DR EMBL; AK155378; BAE33229.1; -; mRNA. DR EMBL; BC031987; AAH31987.2; -; mRNA. DR CCDS; CCDS22126.1; -. DR RefSeq; NP_081068.1; NM_026792.3. DR AlphaFoldDB; Q9D1E8; -. DR BioGRID; 206392; 4. DR IntAct; Q9D1E8; 1. DR STRING; 10090.ENSMUSP00000117025; -. DR iPTMnet; Q9D1E8; -. DR PhosphoSitePlus; Q9D1E8; -. DR EPD; Q9D1E8; -. DR MaxQB; Q9D1E8; -. DR PaxDb; 10090-ENSMUSP00000117025; -. DR ProteomicsDB; 289924; -. DR Pumba; Q9D1E8; -. DR Antibodypedia; 2138; 360 antibodies from 27 providers. DR Ensembl; ENSMUST00000149565.8; ENSMUSP00000117025.2; ENSMUSG00000031467.11. DR GeneID; 52123; -. DR KEGG; mmu:52123; -. DR UCSC; uc009kzv.1; mouse. DR AGR; MGI:1196345; -. DR CTD; 55326; -. DR MGI; MGI:1196345; Agpat5. DR VEuPathDB; HostDB:ENSMUSG00000031467; -. DR eggNOG; KOG1505; Eukaryota. DR GeneTree; ENSGT00950000182836; -. DR InParanoid; Q9D1E8; -. DR OMA; CPRIHIH; -. DR OrthoDB; 2906776at2759; -. DR PhylomeDB; Q9D1E8; -. DR TreeFam; TF314346; -. DR Reactome; R-MMU-1483166; Synthesis of PA. DR UniPathway; UPA00557; UER00613. DR BioGRID-ORCS; 52123; 3 hits in 78 CRISPR screens. DR ChiTaRS; Agpat5; mouse. DR PRO; PR:Q9D1E8; -. DR Proteomes; UP000000589; Chromosome 8. DR RNAct; Q9D1E8; Protein. DR Bgee; ENSMUSG00000031467; Expressed in triceps brachii and 270 other cell types or tissues. DR ExpressionAtlas; Q9D1E8; baseline and differential. DR GO; GO:0012505; C:endomembrane system; IBA:GO_Central. DR GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central. DR GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB. DR GO; GO:0005739; C:mitochondrion; HDA:MGI. DR GO; GO:0005635; C:nuclear envelope; ISS:UniProtKB. DR GO; GO:0005730; C:nucleolus; ISO:MGI. DR GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; IDA:MGI. DR GO; GO:0016746; F:acyltransferase activity; IBA:GO_Central. DR GO; GO:0006639; P:acylglycerol metabolic process; IDA:MGI. DR GO; GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway. DR GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IGI:MGI. DR GO; GO:0036149; P:phosphatidylinositol acyl-chain remodeling; IBA:GO_Central. DR CDD; cd07990; LPLAT_LCLAT1-like; 1. DR InterPro; IPR032098; Acyltransf_C. DR InterPro; IPR002123; Plipid/glycerol_acylTrfase. DR PANTHER; PTHR10983:SF76; 1-ACYL-SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE EPSILON; 1. DR PANTHER; PTHR10983; 1-ACYLGLYCEROL-3-PHOSPHATE ACYLTRANSFERASE-RELATED; 1. DR Pfam; PF16076; Acyltransf_C; 1. DR Pfam; PF01553; Acyltransferase; 1. DR SMART; SM00563; PlsC; 1. DR SUPFAM; SSF69593; Glycerol-3-phosphate (1)-acyltransferase; 1. DR Genevisible; Q9D1E8; MM. PE 1: Evidence at protein level; KW Acyltransferase; Endoplasmic reticulum; Lipid biosynthesis; KW Lipid metabolism; Membrane; Mitochondrion; Nucleus; KW Phospholipid biosynthesis; Phospholipid metabolism; Reference proteome; KW Transferase; Transmembrane; Transmembrane helix. FT CHAIN 1..365 FT /note="1-acyl-sn-glycerol-3-phosphate acyltransferase FT epsilon" FT /id="PRO_0000208201" FT TRANSMEM 15..35 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 345..365 FT /note="Helical" FT /evidence="ECO:0000255" FT MOTIF 93..98 FT /note="HXXXXD motif" FT /evidence="ECO:0000250|UniProtKB:Q9D517" FT CONFLICT 80 FT /note="L -> W (in Ref. 1; AAN75571)" FT /evidence="ECO:0000305" FT CONFLICT 128 FT /note="L -> M (in Ref. 1; AAN75571)" FT /evidence="ECO:0000305" SQ SEQUENCE 365 AA; 42202 MW; C13E14759610E19B CRC64; MLLSLVLHTY SMRYLLPSVL LLGSAPTYLL AWTLWRVLSA LMPARLYQRV DDRLYCVYQN MVLFFFENYT GVQILLYGDL PKNKENVIYL ANHQSTVDWI VADMLAARQD ALGHVRYVLK DKLKWLPLYG FYFAQHGGIY VKRSAKFNDK EMRSKLQSYV NAGTPMYLVI FPEGTRYNAT YTKLLSASQA FAAQRGLAVL KHVLTPRIKA THVAFDSMKS HLDAIYDVTV VYEGNEKGSG KYSNPPSMTE FLCKQCPKLH IHFDRIDRNE VPEEQEHMKK WLHERFEIKD RLLIEFYDSP DPERRNKFPG KSVHSRLSVK KTLPSVLILG SLTAVMLMTE SGRKLYMGTW LYGTLLGCLW FVIKA //